Yung-Ting Chang

Dr. Yung-Ting Chang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2015 in Tumor Biology
Verified
Journal Article
Open access
PDF file
AFAmmad Farooqi
Ammad Farooqi
KLKun-Tzu Li
Kun-Tzu Li
SFSundas Fayyaz
Sundas Fayyaz
YCYung-Ting Chang
Yung-Ting Chang
MIMuhammad Ismail
Muhammad Ismail
HCHsueh-Wei Chang
Hsueh-Wei Chang
Prior research has demonstrated how the endoplasmic reticulum (ER) functions as a multifunctional organelle and as a well-orchestrated protein-folding unit. It consists of sensors which detect stress-induced unfolded/misfolded proteins and it is the place where protein folding is catalyzed with chaperones. During this folding process, an immaculate disulfide bond formation requires an oxidized environment provided by the ER. Protein folding and the generation of reactive oxygen species (ROS) as a protein oxidative byproduct in ER are crosslinked. An ER stress-induced response also mediates the expression of the apoptosis-associated gene C/EBP-homologous protein (CHOP) and death receptor 5 (DR5). ER stress induces the upregulation of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor and opening new horizons for therapeutic research. These findings can be used to maximize TRAIL-induced apoptosis in xenografted mice. This review summarizes the current understanding of the interplay between ER stress and ROS. We also discuss how damage-associated molecular patterns (DAMPs) function as modulators of immunogenic cell death and how natural products and drugs have shown potential in regulating ER stress and ROS in different cancer cell lines. Drugs as inducers and inhibitors of ROS modulation may respectively exert inducible and inhibitory effects on ER stress and unfolded protein response (UPR). Reconceptualization of the molecular crosstalk among ROS modulating effectors, ER stress, and DAMPs will lead to advances in anticancer therapy.

Verified
Journal Article
Open access
PDF file
AFAmmad Farooqi
Ammad Farooqi
CSChih-Wen Shu
Chih-Wen Shu
HHHurng-Wern Huang
Hurng-Wern Huang
HWHui-Ru Wang
Hui-Ru Wang
YCYung-Ting Chang
Yung-Ting Chang
HCHsueh-Wei Chang
Hsueh-Wei Chang
Clinical studies and cancer cell models emphasize the importance of targeting therapies for oral cancer. The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is highly expressed in cancer, and is a selective killing ligand for oral cancer. Signaling proteins in the wingless-type mouse mammary tumor virus (MMTV) integration site family (Wnt), Sonic hedgehog (SHH), and transforming growth factor β (TGFβ) pathways may regulate cell proliferation, migration, and apoptosis. Accordingly, the genes encoding these signaling proteins are potential targets for oral cancer therapy. In this review, we focus on recent advances in targeting therapies for oral cancer and discuss the gene targets within TRAIL, Wnt, SHH, and TGFβ signaling for oral cancer therapies. Oncogenic microRNAs (miRNAs) and tumor suppressor miRNAs targeting the genes encoding these signaling proteins are summarized, and the interactions between Wnt, SHH, TGFβ, and miRNAs are interpreted. With suitable combination treatments, synergistic effects are expected to improve targeting therapies for oral cancer.

1 June 2016 in Archives of Oral Biology
Verified
Journal Article
Closed access
YCYung-Ting Chang
Yung-Ting Chang
CHChiung-Yao Huang
Chiung-Yao Huang
KLKun-Tzu Li
Kun-Tzu Li
RLRueinian Li
Rueinian Li
CLChih-Chuang Liaw
Chih-Chuang Liaw
HCHsueh-Wei Chang
Hsueh-Wei Chang